But to pharma—with its paper-based control systems—this is alien technology. You can’t really blame pharmaceutical companies for their backward manufacturing habits. In the past, the FDA hasn’t been ...

Faster review times could leave drugmakers vulnerable to litigation, while new Trump administration priorities add more ...

DynoChem Platform Designed to Facilitate API Process Development and Scale-up Already used by 11 of the world’s biggest pharmaceutical companies, the DynoChem (www.scale-up.com) platform was ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new sector-specific U.S. tariffs likely remains weeks away, four official and ...

Within pharmaceutical process development, chemicals previously synthesised at the milligram level require scaling up to gram levels and above. These are often novel chemicals or utilise large ...

Generative AI, once seen as a tool for writers and artists, is now reshaping the high-stakes world of pharma regulation.

Hence, big pharma, through its trade association PhRMA, objected to Sen. Hagan’s proposal, instead arguing for window-dressing reforms to the existing accelerated approval process.

Yet a bottleneck of inefficiency remains in the middle step of the pharma process. Clinical development is a complex process with hundreds of interdependent tasks spread among cross-functional teams.

This month’s B2B focuses on a new cooling tower to serve a pharmaceutical facility’s new process water system. This tower will be a closed-loop, evaporative condenser to operate 24/7/365.

After routine cleaning of metal or glass surfaces of pharmaceutical process tanks, residues may remain and appear as faint whitish or dark stains that cannot be easily wiped off. To clean the ...